Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Prion propagation and toxicity in vivo occur in two distinct mechanistic phases

Abstract

Mammalian prions cause fatal neurodegenerative conditions including Creutzfeldt–Jakob disease in humans and scrapie and bovine spongiform encephalopathy in animals1. Prion infections are typically associated with remarkably prolonged but highly consistent incubation periods followed by a rapid clinical phase. The relationship between prion propagation, generation of neurotoxic species and clinical onset has remained obscure. Prion incubation periods in experimental animals are known to vary inversely with expression level of cellular prion protein. Here we demonstrate that prion propagation in brain proceeds via two distinct phases: a clinically silent exponential phase not rate-limited by prion protein concentration which rapidly reaches a maximal prion titre, followed by a distinct switch to a plateau phase. The latter determines time to clinical onset in a manner inversely proportional to prion protein concentration. These findings demonstrate an uncoupling of infectivity and toxicity. We suggest that prions themselves are not neurotoxic but catalyse the formation of such species from PrPC. Production of neurotoxic species is triggered when prion propagation saturates, leading to a switch from autocatalytic production of infectivity (phase 1) to a toxic (phase 2) pathway.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Figure 1: Survival times and levels of infectivity during prion infection.
Figure 2: Kinetics of prion propagation and toxicity.

References

  1. 1

    Collinge, J. Prion diseases of humans and animals: their causes and molecular basis. Annu. Rev. Neurosci. 24, 519–550 (2001)

    CAS  Article  Google Scholar 

  2. 2

    Griffith, J. S. Self-replication and scrapie. Nature 215, 1043–1044 (1967)

    CAS  Article  ADS  Google Scholar 

  3. 3

    Prusiner, S. B. Novel proteinaceous infectious particles cause scrapie. Science 216, 136–144 (1982)

    CAS  Article  ADS  Google Scholar 

  4. 4

    Gajdusek, D. C. Transmissible and non-transmissible amyloidoses: autocatalytic post-translational conversion of host precursor proteins to β- pleated sheet configurations. J. Neuroimmunol. 20, 95–110 (1988)

    CAS  Article  Google Scholar 

  5. 5

    Come, J. H., Fraser, P. E. & Lansbury, P. T. J. A kinetic model for amyloid formation in the prion diseases: importance of seeding. Proc. Natl Acad. Sci. USA 90, 5959–5963 (1993)

    CAS  Article  ADS  Google Scholar 

  6. 6

    Collinge, J. & Clarke, A. A general model of prion strains and their pathogenicity. Science 318, 930–936 (2007)

    CAS  Article  ADS  Google Scholar 

  7. 7

    Collinge, J. et al. Kuru in the 21st century–an acquired human prion disease with very long incubation periods. Lancet 367, 2068–2074 (2006)

    Article  Google Scholar 

  8. 8

    Scott, M. et al. Transgenic mice expressing hamster prion protein produce species- specific scrapie infectivity and amyloid plaques. Cell 59, 847–857 (1989)

    CAS  Article  Google Scholar 

  9. 9

    Büeler, H. et al. High prion and PrPSc levels but delayed onset of disease in scrapie-inoculated mice heterozygous for a disrupted PrP gene. Mol. Med. 1, 19–30 (1994)

    Article  Google Scholar 

  10. 10

    Hill, A. F. et al. Species barrier independent prion replication in apparently resistant species. Proc. Natl Acad. Sci. USA 97, 10248–10253 (2000)

    CAS  Article  ADS  Google Scholar 

  11. 11

    Hill, A. F. & Collinge, J. Subclinical prion infection. Trends Microbiol. 11, 578–584 (2003)

    CAS  Article  Google Scholar 

  12. 12

    Dickinson, A. G., Meikle, V. M. & Fraser, H. Genetical control of the concentration of ME7 scrapie agent in the brain of mice. J. Comp. Pathol. 79, 15–22 (1969)

    CAS  Article  Google Scholar 

  13. 13

    Dickinson, A. G. Host-pathogen interactions in scrapie. Genetics 79 (Suppl). 387–395 (1975)

    PubMed  Google Scholar 

  14. 14

    Kimberlin, R. H. & Walker, C. A. Pathogenesis of mouse scrapie: dynamics of agent replication in spleen, spinal cord and brain after infection by different routes. J. Comp. Pathol. 89, 551–562 (1979)

    CAS  Article  Google Scholar 

  15. 15

    Kimberlin, R. H. & Walker, C. A. Pathogenesis of scrapie (strain 263K) in hamsters infected intracerebrally, intraperitoneally or intraocularly. J. Gen. Virol. 67, 255–263 (1986)

    Article  Google Scholar 

  16. 16

    Czub, M., Braig, H. R. & Diringer, H. Pathogenesis of scrapie: study of the temporal development of clinical symptoms, of infectivity titres and scrapie-associated fibrils in brains of hamsters infected intraperitoneally. J. Gen. Virol. 67, 2005–2009 (1986)

    Article  Google Scholar 

  17. 17

    Oesch, B. et al. A cellular gene encodes scrapie Prp 27-30 protein. Cell 40, 735–746 (1985)

    CAS  Article  Google Scholar 

  18. 18

    Klohn, P., Stoltze, L., Flechsig, E., Enari, M. & Weissmann, C. A quantitative, highly sensitive cell-based infectivity assay for mouse scrapie prions. Proc. Natl Acad. Sci. USA 100, 11666–11671 (2003)

    Article  ADS  Google Scholar 

  19. 19

    Büeler, H. et al. Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature 356, 577–582 (1992)

    Article  ADS  Google Scholar 

  20. 20

    Fischer, M. et al. Prion protein (PrP) with amino-proximal deletions restoring susceptibility of PrP knockout mice to scrapie. EMBO J. 15, 1255–1264 (1996)

    CAS  Article  Google Scholar 

  21. 21

    Büeler, H. et al. Mice devoid of PrP are resistant to scrapie. Cell 73, 1339–1347 (1993)

    Article  Google Scholar 

  22. 22

    Dickinson, A. G., Fraser, H., Meikle, V. M. & Outram, G. W. Competition between different scrapie agents in mice. Nat. New Biol. 237, 244–245 (1972)

    CAS  Article  Google Scholar 

  23. 23

    Safar, J. et al. Eight prion strains PrPSc molecules with different conformations. Nature Med. 4, 1157–1165 (1998)

    CAS  Article  Google Scholar 

  24. 24

    Cronier, S. et al. Detection and characterization of proteinase K-sensitive disease-related prion protein with thermolysin. Biochem. J. 416, 297–305 (2008)

    CAS  Article  Google Scholar 

  25. 25

    Li, J., Browning, S., Mahal, S. P., Oelschlegel, A. M. & Weissmann, C. Darwinian evolution of prions in cell culture. Science 327, 869–872 (2010)

    CAS  Article  ADS  Google Scholar 

  26. 26

    Solforosi, L. et al. Cross-linking cellular prion protein triggers neuronal apoptosis in vivo. Science 303, 1514–1516 (2004)

    CAS  Article  ADS  Google Scholar 

  27. 27

    Race, R., Raines, A., Raymond, G. J., Caughey, B. & Chesebro, B. Long-term subclinical carrier state precedes scrapie replication and adaptation in a resistant species: analogies to bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease in humans. J. Virol. 75, 10106–10112 (2001)

    CAS  Article  Google Scholar 

  28. 28

    Thackray, A. M., Klein, M. A., Aguzzi, A. & Bujdoso, R. Chronic subclinical prion disease induced by low-dose inoculum. J. Virol. 76, 2510–2517 (2002)

    CAS  Article  Google Scholar 

  29. 29

    Thackray, A. M., Klein, M. A. & Bujdoso, R. Subclinical prion disease induced by oral inoculation. J. Virol. 77, 7991–7998 (2003)

    CAS  Article  Google Scholar 

  30. 30

    Asante, E. et al. BSE prions propagate as either variant CJD-like or sporadic CJD-like prion strains in transgenic mice expressing human prion protein. EMBO J. 21, 6358–6366 (2002)

    CAS  Article  Google Scholar 

Download references

Acknowledgements

This work was funded by the UK Medical Research Council. We thank J. Wadsworth for critical review of the manuscript, S. Walker for statistical advice, staff of our Biological Services Facility for animal care and technical assistance and R. Young for preparation of figures.

Author information

Affiliations

Authors

Contributions

M.K.S., H.A.-D. and B.S. performed the work. M.K.S., A.R.C. and J.C. designed the study and analysed the data. J.C. drafted the manuscript. All authors discussed the results and commented on the manuscript.

Corresponding author

Correspondence to John Collinge.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

PowerPoint slides

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Sandberg, M., Al-Doujaily, H., Sharps, B. et al. Prion propagation and toxicity in vivo occur in two distinct mechanistic phases. Nature 470, 540–542 (2011). https://doi.org/10.1038/nature09768

Download citation

Further reading

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing